Applications

Cervical Cancer Detection

DiaCarta QuantiVirus® HPV test detects HPV oncogenes E6 and E7 mRNA from 14 high-risk HPV types (16, 18, 31, 33,35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) directly from cervical samples (PreservCyt® and SurePath® preservation fluid)for cervical cancer screening without RNA extraction and RT-PCR 
Read more »
Description
DiaCarta QuantiVirus® HPV test detects HPV oncogenes E6 and E7 mRNA from 14 high-risk HPV types (16, 18, 31, 33,35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) directly from cervical samples (PreservCyt® and SurePath® preservation fluid)for cervical cancer screening without RNA extraction and RT-PCR.
 
Benefits
1. High sensitivity and specificity.
 
2. Minimal hands-on required minimizing un-necessary errors.
 
3. Assay directly from cervical samples (PreservCyt® and SurePath® preservation fluid) without DNA / RNA purification. 
 
4. No cleanroom required and a small laboratory foot-print to operate.
 
5.  Highly sensitive and specific using branched DNA technology.
 
6.  CE, IVD and China FDA marks
 
Target customers
Laboratories providing screening for cervical cancer.
 
Products
 
Cat Description Size Enquiry
DC-01-0001 HPV E6/E7 mRNA Completed Kit for Cervical Cancer (92 test). 1 each Contact Us
 
HPV E6/E7 mRNA Completed Kit for Cervical Cancer (92 test) Consists of:
          All the reagents for performing 92 tests in the 96-well plate format and instruction manual.
          Note: additional equipment required, which are not supplied in the kit.